THC (Tenet Healthcare Corporation New) Stock Analysis - AI Report

Tenet Healthcare Corporation New (THC) is a publicly traded Healthcare sector company. As of May 20, 2026, THC trades at $185.73 with a market cap of $16.58B and a P/E ratio of 12.05. THC moved -1.88% today. Year to date, THC is -9.47%; over the trailing twelve months it is +11.12%. Its 52-week range spans $109.82 to $247.21. Analyst consensus is strong buy with an average price target of $248.27. Rallies surfaces THC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on THC?

Rallies AI research for THC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

THC Key Metrics

Key financial metrics for THC
MetricValue
Price$185.73
Market Cap$16.58B
P/E Ratio12.05
EPS$15.61
Dividend Yield0.00%
52-Week High$247.21
52-Week Low$109.82
Volume1.58M
Avg Volume0
Revenue (TTM)$21.31B
Net Income$2.37B
Gross Margin0.00%

Latest THC News

Recent THC Insider Trades

  • Arbour Paola M sold 6.50K (~$1.55M) on Mar 11, 2026.
  • Arnst Thomas W sold 4.71K (~$1.12M) on Mar 9, 2026.
  • Arnst Thomas W sold 3.29K (~$786.87K) on Mar 9, 2026.

THC Analyst Consensus

15 analysts cover THC: 0 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $248.27.

Common questions about THC

What is the AI research view on THC?
Rallies AI research for THC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for THC?
Rallies AI research for THC combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is THC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for THC. It does not provide personalized investment advice.
THC

THC